Gilead Sciences has broken ground on a 180,000-square-foot Pharmaceutical Development and Manufacturing Technical Development Center at its Foster City campus. This digitally enabled facility will accelerate biologics development through flexible pilot labs, autonomous robotics, and real-time monitoring, complementing adjacent expansions for research and manufacturing. These investments underscore Gilead’s commitment to next-generation therapies and U.S. biopharma innovation, aiming to create thousands of jobs and boost domestic biologics production capabilities.